Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Joesph Roenker

Physician Assistant Norfolk, VA Physician Assistant

NPI 1942612817 CMS profile 11214111

600 Gresham Dr, Norfolk, VA 23507

Open in the dashboard

General payments

$6,363

143 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joesph Roenker of Norfolk, VA is reported in the CMS Open Payments database as having received $6,363 across 143 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $681 21
2024 General $2,446 36
2023 General $530 18
2022 General $1,262 36
2021 General $1,443 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joesph Roenker
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Joesph Roenker were reported at $681. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Joesph Roenker Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,443 $132 $37–$438 $132
2022 $1,262 $155 $48–$522 $149
2023 $530 $167 $52–$557 $160
2024 $2,446 $178 $55–$600 $164
2025 $681 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $2,845 90 payments
  2. Abbott Laboratories $2,479 26 payments
  3. Edwards Lifesciences Corporation $813 23 payments
  4. Philips Electronics North America Corporation $95 1 payment
  5. W. L. Gore & Associates, Inc. $95 1 payment
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $21 1 payment
  7. Novartis Pharmaceuticals Corporation $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,369 140 payments
  2. Travel and Lodging $993 3 payments
Products named General payments · program years 2021–2025
  1. COREVALVE EVOLUT R $1,678 58 payments
  2. MITRACLIP Vascular $1,453 9 payments
  3. MitraClip System $613 11 payments
  4. Avalus $495 21 payments
  5. CoreValve Evolut $404 5 payments
  6. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $301 13 payments
  7. SAPIEN 3 Ultra RESILIA $178 2 payments
  8. MITRACLIP Structural Heart $164 2 payments
  9. 3F $131 4 payments
  10. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $128 3 payments
  11. Other $323 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

193

Median for Physician Assistant: 241

Drug cost

$63,107

Median for Physician Assistant: $4,110

Branded share of claims

55.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 64 $57,051
Brilinta Ticagrelor Brand 12 $5,268
Clopidogrel Clopidogrel Bisulfate Brand 31 $259
Metoprolol Succinate Generic 22 $189
Furosemide Generic 37 $171
Carvedilol Generic 16 $102
Amlodipine Besylate Generic 11 $67

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$14,025

Medicare's payments for the services billed

Medicare patients

214

Average age 80

Services billed

233

101 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 70%
Ischemic heart disease 67%
Atrial fibrillation 53%
Arthritis 53%
Chronic kidney disease 48%
Diabetes 41%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

143 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record